Glioblastoma stem cells are metabolically reprogrammed under hypoxic conditions by upregulating glucose transporters, glucose uptake, and glycogen and lipid storage, in a process that results from the activation of PPARα by hypoxia-inducible factor-1 (HIF-1). The gene discussed is PPARA; the disease is glioblastoma.